Profiling of H3K27ac landscape in five immune cell types from rheumatoid arthritis patients and healthy controls

The DAC of Department of clinical immunology, Xijing hospital has been established to provide oversight and guidance on data access issues. The Committee monitors the progress of all data requests and also reviews any requests for access that raise particular issues.

Ownership and Intellectual Property Department of clinical immunology,Xijing hospital is the only owner of the data. We have a rigorous review process for researchers who want to use the data. Our data is restricted to open access. Researchers who want to use the data must submit application for use to the DAC of Department of clinical immunology. Data only shared with bona fide researchers Requesters should be employees of a recognised academic institution, health service organisation or charitable research organisation with experience in medical research. Requestors should be able to demonstrate, through their peer reviewed publications in the area of interest, their ability to carry out the proposed study. Their organisation should have formal policies and procedures to comply with any legal, ethical or data protection constraints and to ensure that the dataset is stored securely and used responsibly. Independent Oversight of Access An Independent Access Committee has been established to provide oversight and guidance on data access issues. The Committee will monitor the progress of all data requests. Protecting the Identity of Participants Safeguards will be maintained to ensure the anonymity and confidentiality of participants’ data. Researchers will enter a legal agreement not to make any attempt to identify participants, and the data provided to researchers will not contain any personally identifiable variables.